Prior to joining MODAG as CSO, Prof. Dr. Giese was Acting Head of Department at the Center for Neuropathology and Prion Research (ZNP) at the University of Munich and Acting Head of the German Reference Center for Neurodegenerative Diseases (DGNN). He holds a Bachelor of Science from the University College London, Medical Licenses from the University of Kiel, and a Doctor of Medicine from the University of Göttingen.
Dr. Giese is a board-certified neuropathologist, and has published over 150 scientific publications, cited more than 14,000 times. His scientific work focuses on the role of protein aggregation in neurodegenerative diseases. Prof. Dr. Giese developed new high-throughput methods for the detection of protein oligomers and for the screening of aggregation inhibitors based on single particle spectroscopy. Utilizing this technology, he identified novel aggregation inhibitors with excellent medical-chemical properties and high in vivo efficacy. Based on these findings, he co-founded MODAG in 2013.